Ringa Virginie, Légaré France, Dodin Sylvie, Norton Joanna, Godin Gaston, Bréart Gérard
INSERM National Institute of Health and Medical Research U149, Epidemiological Research Unit on Perinatal Health and Women's Health, Villejuif, France.
Menopause. 2004 Jan-Feb;11(1):89-97. doi: 10.1097/01.GME.0000072202.41124.1B.
Our objective was to compare physician characteristics associated with high-frequency hormone therapy (HT) prescription between gynecologists and general practitioners (GPs) within and between France and Quebec, Canada.
A self-administered mail survey was sent to a representative sample of 2,000 physicians in France and 1,000 physicians in Quebec. High-frequency prescribers were those who reported prescribing HT to more than 70% of their postmenopausal patients. The following characteristics were included in the analysis: country, specialty, age, gender, characteristics of the practice (solo or group, private or public, rural or urban, number of patients seen daily, duration of practice, percentage of women 45 years or older), teaching or research activities, participation in education course on HT, and practice patterns relating to menopausal women (having patient education materials available, providing materials to patients, and discussing the possibility of HT).
The analysis covered 974 physicians in France (389 GPs and 585 gynecologists) and 452 physicians in Quebec, Canada (318 GPs and 134 gynecologists). Despite differences in health care, in both countries gynecologists were more likely to be high-frequency prescribers than were GPs, although this difference was smaller in Quebec. Canadian physicians were more likely to prescribe HT. The difference between countries was greatest among GPs. Except for nationality and practice patterns designed to provide women with information, none of the physician characteristics was associated with high-frequency prescription among GPs. Among gynecologists, only the number of patients per day and the provision of information were associated with high-frequency prescription.
Notwithstanding a common language, differences in the prescription pattern of HT between countries were greatest at the level of primary care than secondary care. In both countries, specialists were more likely to prescribe HT than were GPs. Implementation of clinical practice guidelines to set baseline standards in the field of menopausal health remains a challenge but will need to take into account cultural characteristics as well as level of medical care.
我们的目的是比较法国和加拿大魁北克省内及之间妇科医生和全科医生(GP)中与高频激素疗法(HT)处方相关的医生特征。
向法国的2000名医生和魁北克的1000名医生的代表性样本发送了一份自填式邮件调查问卷。高频处方者是那些报告为超过70%的绝经后患者开具HT的医生。分析中纳入了以下特征:国家、专业、年龄、性别、执业特征(单人或团体、私立或公立、农村或城市、每日看诊患者数量、执业时长、45岁及以上女性患者的比例)、教学或研究活动、参与HT教育课程情况以及与绝经后女性相关的执业模式(有患者教育资料、向患者提供资料以及讨论HT的可能性)。
分析涵盖了法国的974名医生(389名全科医生和585名妇科医生)以及加拿大魁北克的452名医生(318名全科医生和134名妇科医生)。尽管医疗保健存在差异,但在这两个国家,妇科医生比全科医生更有可能成为高频处方者,不过这种差异在魁北克较小。加拿大医生更有可能开具HT。两国之间的差异在全科医生中最为显著。除了国籍和旨在为女性提供信息的执业模式外,全科医生的其他医生特征均与高频处方无关。在妇科医生中,只有每日患者数量和信息提供与高频处方有关。
尽管使用共同语言,但国家之间HT处方模式的差异在初级保健层面比二级保健层面更大。在这两个国家,专科医生比全科医生更有可能开具HT。实施临床实践指南以设定绝经健康领域的基线标准仍然是一项挑战,但需要考虑文化特征以及医疗保健水平。